Clinical Trial: Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792681) titled 'Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults' on Aug. 24.

Brief Summary: The purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Migraine, With or Without Aura

Intervention: DRUG: BR005-036C

Dose 1, Oral tablet

DRUG: BR005-036C

Dose 2, Oral tablet

DRUG: Placebo

Placebo tablet to match BR005-036C dose, Oral

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Brise Pharmaceuticals Co., Ltd.

Disclaimer: Curated by HT Syndication....